Fig. 2

Flowchart of patient selection for study population. * All exclusion criteria were assessed during the 365-day baseline period unless otherwise noted. † Conditions other than T2D that could cause DKD included the following: glomerulonephritis, focal glomerulosclerosis/focal sclerosing glomerulonephritis, membranous nephropathy, membranoproliferative glomerulonephritis type 1/diffuse membranoproliferative glomerulosclerosis, immunoglobin A nephropathy/Berger’s disease, rapidly progressive, systemic lupus erythematosus nephritis, glomerulonephritis, other proliferative glomerulonephritis, Wegener’s granulomatosis, other vasculitis with kidney involvement, interstitial nephritis/pyelonephritis from analgesic abuse, gouty nephropathy, acquired obstructive uropathy, chronic pyelonephritis/reflux nephropathy, chronic interstitial nephritis, acute interstitial nephritis, urolithiasis, renal artery stenosis, renal artery occlusion, adult polycystic kidney disease, malignant renal tumor, multiple myeloma, acquired immunodeficiency syndrome, nephropathy and tubular necrosis, renal agenesis, dysgenesis, hypoplasia, and sickle cell disease. Abbreviations: CDM = Clinformatics Data Mart, DKD = diabetic kidney disease, SGLT2i = sodium-glucose co-transporter-2 inhibitor, T2D = type 2 diabetes